184 related articles for article (PubMed ID: 21039305)
1. Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion.
Rivière F; Gille T; Le Tinier JY; Gharbi N; Khalil A; Wislez M; Cadranel J
Scand J Infect Dis; 2011 Feb; 43(2):112-4. PubMed ID: 21039305
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
[TBL] [Abstract][Full Text] [Related]
3. Intralesional cidofovir as adjuvant for the successful management of aggressive respiratory papillomatosis in an infant.
Durvasula VS; Richter GT
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1912-5. PubMed ID: 24063771
[TBL] [Abstract][Full Text] [Related]
4. Letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Dikkers FG
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1789. PubMed ID: 24012217
[No Abstract] [Full Text] [Related]
5. Systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis.
Clamp PJ; Saunders MW
Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):323-8. PubMed ID: 23369614
[TBL] [Abstract][Full Text] [Related]
6. Response to Dikkers letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".
Clamp PJ; Saunders MW
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1789. PubMed ID: 24021212
[No Abstract] [Full Text] [Related]
7. Current use of intralesional cidofovir for recurrent respiratory papillomatosis.
Derkay CS; Volsky PG; Rosen CA; Pransky SM; McMurray JS; Chadha NK; Froehlich P
Laryngoscope; 2013 Mar; 123(3):705-12. PubMed ID: 23070868
[TBL] [Abstract][Full Text] [Related]
8. Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Tjon Pian Gi RE; Dietz A; Djukic V; Eckel HE; Friedrich G; Golusinski W; Hantzakos A; Lawson G; Remacle M; Rihkanen H; Dikkers FG
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):361-2. PubMed ID: 22020697
[No Abstract] [Full Text] [Related]
9. Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis.
Ksiazek J; Prager JD; Sun GH; Wood RE; Arjmand EM
Otolaryngol Head Neck Surg; 2011 Apr; 144(4):639-41. PubMed ID: 21493248
[TBL] [Abstract][Full Text] [Related]
10. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
Donne AJ; Rothera MP; Homer JJ
Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
[TBL] [Abstract][Full Text] [Related]
11. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
[TBL] [Abstract][Full Text] [Related]
13. Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.
Grasso M; Remacle M; Bachy V; Van Der Vorst S; Lawson G
Eur Arch Otorhinolaryngol; 2014 Nov; 271(11):2983-90. PubMed ID: 24756616
[TBL] [Abstract][Full Text] [Related]
14. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
[TBL] [Abstract][Full Text] [Related]
15. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
Donne AJ; Hampson L; He XT; Day PJ; Salway F; Rothera MP; Homer JJ; Hampson IN
Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
[TBL] [Abstract][Full Text] [Related]
16. Is recurrent respiratory papillomatosis a manageable or curable disease?
Kim HT; Baizhumanova AS
Laryngoscope; 2016 Jun; 126(6):1359-64. PubMed ID: 26608928
[TBL] [Abstract][Full Text] [Related]
17. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
[TBL] [Abstract][Full Text] [Related]
18. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
[TBL] [Abstract][Full Text] [Related]
19. The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors.
San Giorgi MR; Tjon Pian Gi RE; Dikkers FG
Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1819-20. PubMed ID: 25351501
[No Abstract] [Full Text] [Related]
20. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Mikolajczak S; Quante G; Weissenborn S; Wafaisade A; Wieland U; Lüers JC; Klussmann JP; Beutner D
Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
